Hongryull Pyo

A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2.

Hongryull Pyo, Hak Choy, George P. Amorino et al. · PubMed · 2001 · 186 citations

Radiation Effect, Radiation Exposure, Cell Death +19

Real world data of durvalumab consolidation after chemoradiotherapy in stage III non-small-cell lung cancer

Hyun Ae Jung, Jae Myoung Noh, Jong‐Mu Sun et al. · Lung Cancer · 2020 · 133 citations

Medicine, Cancer Management, Bronchial Neoplasm +8

Radiosensitivity Enhancement by Celecoxib, a Cyclooxygenase (COX)-2 Selective Inhibitor, via COX-2–Dependent Cell Cycle Regulation on Human Cancer Cells Expressing Differential COX-2 Levels

You Keun Shin, Ji Sun Park, Hyun Seok Kim et al. · Cancer Research · 2005 · 107 citations · Full text

Phase III trial of concurrent thoracic radiotherapy with either first- or third-cycle chemotherapy for limited-disease small-cell lung cancer

Jong‐Mu Sun, Yong Chan Ahn, Eun Kyung Choi et al. · Annals of Oncology · 2013 · 105 citations · Full text

Adaptive Radiotherapy, Concurrent Thoracic Radiotherapy, Radiation Therapy +9

Treatment-Related Pneumonitis and Acute Esophagitis in Non–Small-Cell Lung Cancer Patients Treated With Chemotherapy and Helical Tomotherapy

Changhoon Song, Hongryull Pyo, Sung Ho Moon et al. · International Journal of Radiation Oncology*Biology*Physics · 2010 · 82 citations

Esophageal Cancer, Treatment-related Pneumonitis, Acute Esophagitis +8